Latest In Vitro Diagnostics (IVD) News

Advanced Biological Laboratories' DeepChek® and ViroScore® Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic UseAdvanced Biological Laboratories (ABL) announced today that DeepChek® and ViroScore® Suite clinical genotyping solutions are now CE-IVD (In Vitro Diagnostics) approved for commercial use in Europe and other countries that recognise CE certification. This approval is further validating the use of our next generation sequencing (NGS) downstream an...

UBM Canon and MD+DI Proudly Announce 25 Innovative Products as Winners of the 2012 Medical Design Excellence AwardsPHILADELPHIA, May 25, 2012 /PRNewswire/ -- The winning products in this year's Medical Design Excellence Awards (MDEA) competition, presented by UBM Canon, were announced at a presentation ceremony held May 23 inside the Philadelphia Marriott Downtown hotel. The ceremony was held in conjunction with the MD&M East Event (www.MDMEast.com) at the adjacent Pennsylvania Convention Center. At the ce...

The Pancreatic Cancer Research & Education Act (S.362) Reaches 50 Senate Co-Sponsors and Majority of Senate Help CommitteeMANHATTAN BEACH, Calif., May 25, 2012 /PRNewswire/ -- The Pancreatic Cancer Action Network is calling on Congress to pass the Pancreatic Cancer Research & Education Act (S. 362/H.R. 733). The bill reached a critical point today with Senator Johnny Isakson (R-GA) signing on as the 50th co-sponsor of the lifesaving legislation and with his support, the bill also has majority of the Senate...

True Diagnostics wins CE mark approval for TrueDX Platform,TSH testTrue Diagnostics has obtained CE mark approval for its TrueDX Platform and thyroid stimulating hormone (TSH) test.

Clear Criteria and Formal Selection Committees Make Choosing Diagnostics Partners Less TrickyBy David Richardson, Research Team Leader Choosing a partner for the development of a companion diagnostic can have far reaching consequences. Making the right partner connection can prove lucrative. Unfortunately for decision makers, selecting the w...

MDxHealth: Annual and Extraordinary General Shareholders’ MeetingRegulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Annual and Extraordinary General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Annual General Meeting, including th...

HIGH-TECH DIAGNOSETOOLS AUS ÖSTERREICH SIND EUROPAREIFRisikokapitalgeber tecnet unterstützt Anagnostics´ Technologie zur In-vitro-Diagnostik St. Pölten / St. Valentin, 24. Mai 2012 – Ob Drogen im Urin oder Mutationen in tumor-relevanten Genen – mit einer neu entwickelten Diagnosemethode s...

Basilea participates in public-private collaboration to tackle antibiotic resistanceBasilea Pharmaceutica AG / Basilea participates in public-private collaboration to tackle antibiotic resistance . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Basel, Switzerland, May 25, 2012 - Basilea Pharmaceutica Ltd. welcomes the launch in Europe of a pioneering approach to antibiotic research that will see pharmaceu...

Cepheid to launch Xpert CT/NG and Xpert CT in Europe for rapid detection, differentiation of chlamydia & gonorrhoeaeCepheid, a leading molecular diagnostics company, has received CE marking for Xpert CT/NG and Xpert CT. The company announced that the shipment is expected to begin immediately.

Site-specific DICER and DROSHA RNA products control the DNA-damage responseNon-coding RNAs (ncRNAs) are involved in an increasingly recognized number of cellular events. Some ncRNAs are processed by DICER and DROSHA RNases to give rise to small double-stranded RNAs involved in RNA interference (RNAi). The DNA-damage respons...

India steps up efforts to battle rising tide of diabetesIndia is combining a string of initiatives, ranging from an ongoing screening programme which now includes a pilot covering school children, research studies and support for the development of cut-price diagnostics, to tackle the growing incidence of...

Pacific Dental to buy LED Medical VELscope Vx systemsPacific Dental Services has entered into a three year agreement to purchase LED Medical Diagnostics' 400 VELscope Vx systems.

AspenBio Appoints Diagnostics Industry Veteran Don Hurd as Senior Vice President and Chief Commercial OfficerAspenBio Pharma, Inc. (Nasdaq: APPY), today announced that Don Hurd has been appointed to the new position of Senior Vice President and Chief Commercial Officer, effective May 23, 2012. Mr. Hurd brings to AspenBio Pharma over 30 years of experience in the medical diagnostic and device industry with a diverse background in sales, marketing, strategic planni...

Exciting New Research Results Reported at the Recent European Society of Cardiology Heart Failure Congress in BelgradeCritical Diagnostics, makers of the Presage® ST2 Assay, announced today that ST2, an emerging heart disease biomarker, remains at the forefront in cardiology clinical research. At the recently concluded European Heart Failure Congress results describing the clinical utility of ST2 in patients with heart failure were reported in six different summaries....

Thermo Fisher Scientific Declares Quarterly DividendThermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.13 per share. The dividend will be paid on July 16, 2012, to shareholders of record as of June 15, 2012. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE...

Ventana Acquires In Vitro Rights for ERG Protein MeasurementVentana Medical Systems, Inc., a member of the Roche Group, announced it has co-exclusively sublicensed patents from Gen-Probe Incorporated, giving...

In vitro differentiation of mouse embryonic stem cells into inner ear hair cell-like cells using stromal cell conditioned medium

Myriad and Intermountain Healthcare to Collaborate on Molecular DiagnosticsMyriad Genetics, Inc., a molecular diagnostics company, and Intermountain Healthcare, a nonprofit organization that provides affordable medical care, have signed...

Nobelist Speaks Out on Genetic Modification, Synthetic Biology, Stem Cell ResearchASTANA, Kazakhstan, May 24, 2012 /PRNewswire/ -- Sir Richard Roberts, the eminent British biologist and Nobel Prize laureate, said today European opposition to genetically modified organisms is political rather than scientific in nature. He also said "personal medicine" based on human genome research holds large-scale promise to improve the health of the world's people on an individualized b...

New Jersey Military Families Receive Free In Vitro Fertilization Cycle from Reproductive Medicine Associates of New JerseyMORRISTOWN, N.J., May 24, 2012 /PRNewswire/ -- As the country prepares to honor America's heroes this Memorial Day, local fertility clinic Reproductive Medicine Associates of New Jersey (RMANJ) will launch a new program designed to help New Jersey-based active duty United States Military Services personnel and their spouses realize the dream of parenthood. (Logo: http://photos.prnewswire.co...

Stromal Fibroblast–Specific Expression of ADAM-9 Modulates Proliferation and Apoptosis in Melanoma Cells In Vitro and In Vivo

Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) TherapyPORTSMOUTH, N.H., May 24, 2012 /PRNewswire/ -- Novocure™, a commercial stage private oncology company, announced that by June 1, eight additional clinical centers of excellence will join the seven existing clinical centers that provide Novocure's Tumor Treating Fields (TTFields) therapy to patients with recurrent GBM. These fifteen clinical centers are among the leading cancer centers i...

XDx, LabCorp sign new collaboration, license agreementXDx, a molecular diagnostics company, has signed a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp) to develop Lupus Flare Predictor test.

Neovasc Inc. to present at Biofinance 2012 ConferenceTSX Venture Exchange: NVC VANCOUVER, May 24, 2012 /PRNewswire/ - Neovasc Inc. (TSXV: NVC), a developer of novel technologies to treat vascular disease, today announced that the company will present at the BioFinance 2012 Conference on May 30, 2012 at 2:00 pm EDT. The conference will be held at the St. Andrew's Club & Conference Centre in Toronto, Canada. Neovasc management will provide...

Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate to Enter Preclinical Development in Acute Leukemia and Other Hematological CancersOryzon announced today that it is entering preclinical development with its second drug candidate, a first-in-class specific Lysine Specific Demethylase 1 (LSD1) inhibitor for the treatment of hematological cancers. LSD1 inhibition reduced tumor load especially in acute leukemia models by targeting Leukemia Stem Cells, while normal myeloid progenitor cells were spared. Barcelona, Spain (PRWEB) May...

0 1 2 3 4 ›»

buy In Vitro Diagnostics (IVD) market research data and corporate reports now Advertisement